Subsidiaries Silence EContact Us>

▼

165.00p (-3.50p)
Vol: 3699
(15-minute delayed)
View full stock quote

About Us
Platform Technologies
Pipeline
Collaborations
Investor Relations
News & Events
RNAi Hub

Menu
About Us
RNAI Platform
Pipeline
- Overview
- Pre-Clinical development
Collaborations
Investor Relations
News & Events
RNAi Hub
Contact

Author Archives: MEYERS RACHEL [US]

RNAi Modulation Of RSV And Therapeutic Uses Thereof

Posted on January 31, 2013 by MEYERS RACHEL [US]

Posted in News, Other News, Patents, Syndicated

RNAI modulation of RSV and therapeutic uses thereof

Posted on August 14, 2012 by MEYERS RACHEL [US]

Posted in News, Other News, Patents, Syndicated

RNAi MODULATION OF RSV AND THERAPEUTIC USES THEREOF

Posted on December 21, 2011 by MEYERS RACHEL [US]

Posted in News, Other News, Patents, Syndicated

RNAi HUB

19.06.13

Serum miR-21 as a Diagnostic and Prognostic Biomarker in Colorectal Cancer
17.06.13

Release of miRBase 20 approaching
15.06.13

rnai; +16 new citations
14.06.13

rnai; +27 new citations

b Visit The HUB >

Quick Links

Home
About Us
Platform Technologies
Pipeline
Collaborations
Investor Relations
News & Events
RNAi HUB
Site Map

Contact

3 Shortlands
Hammersmith
London W6 8DA
United Kingdom

Tel:+44 (0) 333 9880 140
Fax:+44 (0) 795 731 8494

Copyright © 2013 Silence Therapeutics.
All rights reserved.

Terms of Use
Forward-Looking Statement